BNP Paribas Financial Markets’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-73,526
Closed -$399K 5771
2025
Q2
$399K Sell
73,526
-36,079
-33% -$180K ﹤0.01% 3467
2025
Q1
$380K Buy
109,605
+80,174
+272% +$389K ﹤0.01% 3333
2024
Q4
$303K Buy
+29,431
New +$367K ﹤0.01% 3626

Other funds holding THRD

BNP Paribas Financial Markets's THRD Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 73,526 shares — an estimated $399K sold.

BNP Paribas Financial Markets first reported a position in THRD in Q4 2024 and held it in 3 quarters. The position peaked at $399K in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 73,526 Third Harmonic Bio shares in Q3 2025, an estimated $399K.
  • BNP Paribas Financial Markets first reported a position in Third Harmonic Bio in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Third Harmonic Bio position peaked at $399K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.